Intrastromal voriconazole: the next effective adjunctive treatment for recalcitrant keratomycosis.
DOI:
https://doi.org/10.7439/ijbr.v7i5.3218Keywords:
Delayed awakening, General anaesthesia, Drug effects, Neuromuscular blockersAbstract
Introduction: Fungal keratitis is a commonly encountered infection of the cornea which may lead to moderate to severe visual loss. Aim: To report the result of intra-stromal voriconazole in refractory keratomycosis. Method: Fungal keratitis is a commonly encountered infection of the cornea which may lead to moderate to severe visual loss. It may be caused by several species of fungi and accounts for nearly 50% of all cases of infectious keratitis in developing countries. The penetration of antifungal drugs into the deeper layers of cornea is sub-optimal, thus making it difficult to treat cases of deep fungal keratitis. We report two cases of refractory fungal keratitis; one caused by aspergillus fumigates and other by fusarium as seen on lactophenol cotton blue mount from scrapings. Both the cases were resistant to topical 5% natamycin and 1 % voriconazole and therefore, intra-stromal voriconazole reconstituted to 50 microns / 0.1 ml was injected circumferentially into the mid-stroma in close proximity to the ulcer margins in both the cases. Result: A marked reduction in the size of ulcer (both epithelial defect and infiltrates) was noted at 72 hours after intra-stromal voriconazole. A repeat injection was given in both the cases four days after the first injection. No complications were seen in any of the cases. Conclusion: Intra-stromal voriconazole offers an effective adjunctive in treating refractory keratomycosis as the direct deposition of drug into deeper stroma results into higher therapeutic concentrations into ulcer; thus obviating the need for therapeutic penetrating keratoplasty in such patients.Downloads
References
J. I. Ou and N. R. Acharya.
U. Gopinathan, S. Sharma, P. Garg, and G. Rao.
Polizzi A, Sinischalchi C. Effect of voriconazole on a corneal abscess caused by Fusarium. Acta Ophthalmol Scand 2004; 82:762-4.
Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 2002; 46:1723-7.
Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 2003; 101:183-9.
Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: A review of current literature. Br J Ophthalmol 2008; 92(7):871-8.
Jurkunas U, Langston D, Colby K. Use of voriconazole in the treatment of fungal keratitis. Int Ophthalmol Clin 2007; 47(2):47
Kalaiselvi G , Narayana S , Krishnan T , Sengupta S. Intrastromal voriconazole for deep recalcitrant fungal keratitis: a case series. Br J Ophthalmol 2015 Feb?99 (2):195-8.
Prakash G, Sharma N, Goel M, Titiyal JS, Vajpayee RB. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol 2008; 146:56-9.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.